EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Reverse-QTY code design of active human serum albumin self-assembled amphiphilic nanoparticles for effective anti-tumor drug doxorubicin release in mice

Run Meng iD, Shilei Hao iD, Changfa Sun, Zongkun Hou, Yao Hou, Lili Wang iD, Peiying Deng iD, Jia Deng iD, Yaying Yang, Haijian Xia, Bochu Wang, Rui Qing iD und 1 weitere

Proceedings of the National Academy of Sciences · 2023

DOI: 10.1073/pnas.2220173120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2023. Verfasst von Run Meng und 12 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing 400030, Ch…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Nanoparticles. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Natural Science Foundation of China, Venture and Innovation Support Program for Chongqing Overseas Returnees, Chengdu-Chongqing area double economic circle construction.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

H uman s erum a lbumin (HSA) is a highly water-soluble protein with 67% alpha-helix content and three distinct domains (I, II, and III). HSA offers a great promise in drug delivery with enhanced permeability and retention effect. But it is hindered by protein denaturation during drug entrapment or conjugation that result in distinct cellular transport pathways and reduction of biological activities. Here we report using a protein design approach named r everse- QTY (rQTY) code to convert specific hydrophilic alpha-helices to hydrophobic to alpha-helices. The designed HSA undergo self-assembly of well-ordered nanoparticles with highly biological actives. The hydrophilic amino acids, asparagine (N), glutamine (Q), threonine (T), and tyrosine (Y) in the helical B-subdomains of HSA were systematically replaced by hydrophobic leucine (L), valine (V), and phenylalanine (F). HSA rQTY nanoparticles exhibited efficient cellular internalization through the cell membrane albumin binding protein GP60, or SPARC ( s ecreted p rotein, a cidic and r ich in c ysteine)-mediated pathways. The designed HSA rQTY variants displayed superior biological activities including: i) encapsulation of drug doxorubicin, ii) receptor-mediated cellular transport, iii) tumor cell targeting, and iv) antitumor efficiency compare to denatured HSA nanoparticles. HSA rQTY nanoparticles provided superior tumor targeting and antitumor therapeutic effects compared to the albumin nanoparticles fabricated by antisolvent precipitation method. We believe that the rQTY code is a robust platform for specific hydrophobic modification of functional hydrophilic proteins with clear-defined binding interfaces.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsNanoparticlesHumansAnimalsMiceSerum Albumin, HumanDoxorubicinDrug Delivery SystemsAlbuminsCell Line, TumorDrug Carriers

Stichwörter der Autor:innen

alpha-helix engineeringhydrophilic to hydrophobic conversionprotein designreceptor-mediated drug deliverytreatment of mouse tumors

Substanzen

Serum Albumin, HumanAntineoplastic AgentsDoxorubicinAlbuminsDrug Carriers

Autor:innen und Institutionen

  • Key Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing 400030, China.
  • College of Environment and Resources, Chongqing Technology and Business University, Chongqing 400067, China.
  • Department of Pathology, Molecular Medicine and Tumor Center, Chongqing Medical University, Chongqing 400016, China.
  • Department of Neurosurgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400042, China.
  • State Key Laboratory of Microbial Metabolism, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China.
  • Media Lab, Massachusetts Institute of Technology, Cambridge, MA 02139.

ORCID-Profile: Run Meng, Shilei Hao, Lili Wang, Peiying Deng, Jia Deng, Rui Qing, Shuguang Zhang

Förderung

  • MOST | National Natural Science Foundation of China
  • Venture and Innovation Support Program for Chongqing Overseas Returnees
  • Chengdu-Chongqing area double economic circle construction
  • Graduate research and innovation foundation of Chongqing, China
  • CSU | Fundamental Research Funds for Central Universities of the Central University

Zitieren

APA

Meng, R., Hao, S., Sun, C., Hou, Z., Hou, Y., Wang, L., Deng, P., Deng, J., Yang, Y., Xia, H., Wang, B., Qing, R., & Zhang, S. (2023). Reverse-QTY code design of active human serum albumin self-assembled amphiphilic nanoparticles for effective anti-tumor drug doxorubicin release in mice. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2220173120

Vancouver

Meng R, Hao S, Sun C, Hou Z, Hou Y, Wang L, et al. Reverse-QTY code design of active human serum albumin self-assembled amphiphilic nanoparticles for effective anti-tumor drug doxorubicin release in mice. Proceedings of the National Academy of Sciences. 2023. doi:10.1073/pnas.2220173120

BibTeX
@article{Meng2023,
  author = {Meng, Run and Hao, Shilei and Sun, Changfa and Hou, Zongkun and Hou, Yao and Wang, Lili and Deng, Peiying and Deng, Jia and Yang, Yaying and Xia, Haijian and Wang, Bochu and Qing, Rui and Zhang, Shuguang},
  title = {Reverse-QTY code design of active human serum albumin self-assembled amphiphilic nanoparticles for effective anti-tumor drug doxorubicin release in mice},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2023},
  doi = {10.1073/pnas.2220173120}
}
Kostenlos starten →